British scientists anxiously await their country’s departure from the European Union, President Trump’s views on vaccines may fuel a dangerous movement, and an ethicist helps keep gene-editing research in line.

The Broad Institute can keep its CRISPR patents, Trump’s vaccine safety panel may be back on, and a drug discovered in fish eases seizures in children.

The Massachusetts Institute of Technology is opening a new center for autism research, African-American people with autism face unique challenges, and a colorful video lights up nerve tracts in the brain.

U.S. scientists stranded by new immigration rules get a hand from their peers, the National Institutes of Health is spending millions this year on a critical genomics tool, and more than half of U.S. scientists were born abroad.

The new U.S. president is already rattling nerves, scientists push back against ‘alternative facts,’ and a film about a boy with autism who finds his voice through Disney movies earns an Oscar nomination.

Tensions mount as Trump considers candidates for top health positions, a documentary highlights the overlap between autism and gender dysphoria, and ‘citation cartels’ are gaming the publication system.

Donald Trump seems to see science through the lens of conspiracy, Brexit may spur an exodus of scientific talent from the United Kingdom, and preterm babies show atypical brain activity before birth.

Some women who have children with autism look in the mirror, an accounting firm predicts profit from employees on the spectrum, and 2016 was a slow year for drug approvals.

The jury is still out on autism screening, technology to track wandering children is under attack, and a sensitive Santa Claus sees children on the spectrum.

Drugs for autism and epilepsy have their day in court, a spending bill leaves scientists in limbo, and researchers should speak up to correct misinformation.